Biotech group praises House passage of PAHPA
BIO, an industry organization made up of more than 1,000 biotechnology companies and research centers, singled out Representatives Mike Rogers (R-Michigan) and Gene Green (D-Texas) as deserving of praise for their efforts.
"The reauthorization of PAHPA is an opportunity to build more prepared and resilient communities that are better able to withstand natural disasters, bioterrorist attacks, and outbreaks of infectious disease," BIO's CEO Jim Greenwood said. "We applaud the House for demonstrating its commitment to improving our nation's capacity to prepare and respond to such significant events."
Greenwood said that the original PAHPA legislation represented a major step towards developing a robust public health system in the United States that is capable of responding to a major crisis, whether it is the emergence of a new pandemic or the release of a bioterror agent.
"Passage of PAHPRA demonstrates our nation's commitment to prioritizing health preparedness and response as we do when confronted by other national security issues," Greenwood said. "PAHPRA enables the stable frontline response of the public health and healthcare systems, rather than funding on an emergency-by-emergency basis.
"We thank the House for quickly considering, and passing, this reauthorization, and we look forward to working with the Senate to see a PAHPA reauthorization enacted as early as possible this year."